News

Published on 26 Nov 2024 on Investing.com

Merck to Participate in the Citi 2024 Global Healthcare Conference By...


Article preview image

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and...

NYSE.MRK price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
The Smartest Dividend Stocks to Buy With $3,000 Right Now | The Motley Fool

A company should not only be able to continue funding its payouts, but should also be capable of...

The Motley Fool 28 Nov 2024

Merck to Participate in the Citi 2024 Global Healthcare Conference By...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and...

Investing.com 26 Nov 2024

Merck & Co. (MRK) Fell As It Faced Some Demand Headwinds In China

Columbia Threadneedle Investments, an investment management company released its “Columbia Divide...

Insider Monkey · via Yahoo Finance 26 Nov 2024

Merck Stock Up as Winrevair Meets Goal in Advanced PAH Study

Key Takeaways Merck's stock rose 2% Monday on the back of positive data from a study of a new...

Zacks · via Yahoo Finance 26 Nov 2024

Merck reports ‘positive’ results from Phase 3 ZENITH trial evaluating Winrevair

Merck (MRK) announced positive topline results from the Phase 3 ZENITH study evaluating Winrevair...

TipRanks · via Yahoo Finance 26 Nov 2024

Merck's therapy for rare lung condition shown to help reduce risk of death in...

Winrevair was approved to treat pulmonary arterial hypertension (PAH), a progressive disorder cau...

Reuters · via Yahoo News 25 Nov 2024

Why Is Merck Stock Trading Higher On Monday?

On Monday, Merck & Co Inc (NYSE:MRK) revealed topline results from the Phase 3 ZENITH study evalu...

Benzinga · via Yahoo Finance 25 Nov 2024

Merck & Co., Inc. (MRK): Among the Most Promising Cancer Stocks According to...

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In t...

Insider Monkey · via Yahoo Finance 25 Nov 2024

BMO reiterates Merck Outperform stock rating on trial success By Investing.com

Monday, analysts at BMO Capital reiterated their Outperform rating on shares of Merck (NS:PROR)...

Investing.com 25 Nov 2024

Nvidia's Profit Ruled Last Quarter — Now It's These 8 Stocks' Turn

Nvidia just reported third-quarter profit that doubled — putting it near the top of the S&P 500's...

Investor's Business Daily 25 Nov 2024